All In Biotech

Free tool

FAERS Monitor: Ella

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022474 or its brand name (Ella, Ulipristal Acetate). Reports on generic versions are filed under their own applications.

Reports

512

Serious

456

89% of reports

Hospitalization

70

Death reported

2

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • unintended pregnancy149
  • abortion spontaneous108
  • vaginal haemorrhage74
  • drug ineffective54
  • nausea39
  • pregnancy after post coital contraception36
  • abdominal pain28
  • headache27
  • dizziness26
  • exposure during pregnancy24
  • maternal exposure during pregnancy22
  • abortion induced21
  • vomiting19
  • back pain17
  • fatigue17

Reports by year received

View as table
YearReports
20113
201235
201312
201417
201518
201640
201772
201860
201935
202023
202121
202241
202343
202433
202536
202623

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,647 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pregnancy after post coital contraceptionSignal36665.3484.222,853
unintended pregnancySignal149594.2518.486,442
abortion spontaneousSignal108111.093.911,657
abortion inducedSignal2191.860.41,794
vaginal haemorrhageSignal7470.256.84,977
exposure during pregnancySignal2415.910.7320
maternal exposure during pregnancySignal2210.16.7173
abdominal painSignal284.93.485
back painSignal173.01.921
dizzinessSignal262.11.515
nauseaSignal392.01.520
headache271.81.29
drug ineffective541.71.315
vomiting191.71.14
fatigue170.90.60

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.